TrialAdvances in therapy2021

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial.

Uwe Reuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.